1414 ET -- Pfizer is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Pfizer beat Wall Street's expectations for third-quarter sales and earnings, despite pressure from activist investor Starboard. Sales totaling $17.7 billion and adjusted earnings per share came in at $1.06, beating the $14.9 billion and 61 cents a share, respectively, forecast by analysts surveyed by FactSet. The pharmaceutical company boosted its 2024 revenue outlook to $61 billion to $64 billion and its guidance on adjusted annual earnings to $2.75 to $2.95 a share. Dow Jones & Co. owns Factiva. (jennifer.tershak@wsj.com)
(END) Dow Jones Newswires
October 29, 2024 14:14 ET (18:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments